Matt McIlwain
Matt McIlwain is Managing Director at Madrona. He was Vice President of Business Process at Genuine Parts Company (NYSE:GPC) and Engagement Manager at McKinsey. He is a Board Member at Thira, an Investor at Exa and Terrakotta, and a Board Member at Axiom, EdgeRunner AI, Gradial, Synthesize Bio and Nosis Bio.
-
Madrona Managing Director · current
-
Thira Director 2026–present, Board Member 2026–present · current
-
Axiom Board Member 2025–present · current
-
EdgeRunner AI Director 2025–present, Board Member 2024–present · current
-
Gradial Board Member 2023–present · current
-
Synthesize Bio Board Member 2023–present · current
-
Nosis Bio Board Member 2021–present · current
-
Read AI Director 2021–present, Board Member 2021–present · current
-
A-Alpha Bio Board Member 2021–present, Director 2021 · current
-
Ozette Technologies Board Member 2021–present · current -
Nautilus Biotechnology (NAUT IPO 2021) Board Member 2021–present · current
-
TerraClear Board Member 2018–present · current
-
Booster Board Member 2016–present · current
-
Amperity Board Member 2015–present · current
-
Qumulo Board Member 2012–present, Director 2016 · current
-
Exa Investor 2026–present · current
-
Terrakotta Investor 2025–present · current
-
Vercept Investor 2025–2026 · past
-
XetHub (Aquired by Hugging Face) Board Member 2021–2024 · past
-
OctoML Director 2019 · past
-
Accolade, Inc. (ACCD IPO 2021) Board Observer 2017–2021 · past
-
Snowflake Investor 2017–2020 · past
-
Xnor.ai Board Member 2017–2020, Director 2017–2020 · past
-
Suplari Board Member 2016–2022 · past
-
OctoAI Board Member 2014–2019 · past